期刊文献+

新疆阿克苏地区慢性丙肝患者基因分型与肝脏相关指标 被引量:1

Relationship between genotyping and liver related indexes of patients with chronic hepatitis C in Aksu,Xinjiang
原文传递
导出
摘要 目的通过对慢性丙肝患者HCV基因分型、肝脏超声及肝功能指标检测,评估HCV基因分型分布与病毒RNA拷贝数及肝脏损伤相关指标的关系。方法对就诊阿克苏地区第一人民医院符合入组标准的新疆阿克苏地区维吾尔族丙肝105例患者进行HCV RNA拷贝数检测。采用荧光定量PCR方法进行HCV基因分型。采用全自动生化分析仪及配套商业化试剂盒,对丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、直接胆红素(DIBL)和总胆红素(TIBL)进行测定。彩色多普勒超声系统进行肝脏超声。结果105例丙肝患者基因分型结果显示,1b型46例,2a型41例,3a型8例,3b型8例,6a型2例。1b型为主要的HCV病毒分型,且在RNA拷贝数、AST和ALT水平、肝硬化患者比例较高。统计学分析显示,不同HCV病毒分型与HCV RNA拷贝数之间差异有统计学意义(P=0.032),且在AST和ALT水平方面,1b型、2a型与其他三种分型(3b型、3a型和6a型)差异有统计学意义(P<0.01)。此外,1b型、2a型与其他三种分型在正常肝、肝光点增粗、脂肪肝和肝硬化之间差异有统计学意义(P<0.01)。结论新疆阿克苏地区维吾尔族人HCV基因分型存在地域分布差异。HCV RNA拷贝数、肝脏损伤程度与不同HCV基因分型存在相关性,对指导当地人群丙肝临床诊断和治疗有重要意义。 Objective Though HCV genotyping,liver ultrasound and liver function indicators were used to assess the relationship between HCV genotyping,viral RNA copy number and liver damage related indicators in patients with chronic hepatitis C.Methods A total of 105 Uyghur hepatitis C patients in Aksu,Xinjiang were recruited in our hospital.All patients were carried out a test of HCV RNA copy number.HCV genotyping was performed by fluorescence quantitative PCR method.Fully automatic biochemical analyzer was used for alanine aminotransferase(ALT),aspartate aminotransferase(AST),direct bilirubin(DIBL)and total bilirubin(TIBL)by commercial kits.Color doppler ultrasound system was used for liver ultrasound.Results The genotyping results of 105 Uyghur hepatitis C patients showed that type 1b,2a,3a,3b and 6a were 46,41,8,8 and 2,respectively.Type 1b was the main type of HCV virus.The proportion of RNA copy number,AST and ALT levels,and liver cirrhosis were higher in patients with type 1b.Statistical analysis showed that there was a significant correlation between different HCV virus types and HCV RNA copy number(P=0.032).In terms of AST and ALT levels,there were significant differences between type 1b,type 2a and other genotypes(type 3b and type 3a and type 6a)(P<0.01).In addition,patients with normal liver,enlarged liver spots,fatty liver and cirrhosis have significant differences among type 1b,type 2a and other genotypes(P<0.01).Conclusion There are regional differences in HCV genotyping among Uygur people in Aksu,Xinjiang.HCV RNA copy number and degree of liver damage are correlated with different HCV genotypes,which is of great significance to guide the clinical diagnosis and treatment of HCV in local populations.
作者 郭新文 古丽米热·艾海提 赵玉云 GUO Xin-wen;Gulmira·Aiheiti;ZHAO Yu-yun(Department of Gastroenterology,The First People′s Hospital of Aksu Prefecture,Xinjiang Uygur Autonomous Region,Aksu,Xinjiang 843000,China)
出处 《公共卫生与预防医学》 2021年第6期126-129,共4页 Journal of Public Health and Preventive Medicine
关键词 慢性丙肝 HCV基因分型 肝脏损伤 Chronic hepatitis C HCV genotyping Liver damage
  • 相关文献

参考文献12

二级参考文献84

  • 1Syed Tasleem,Gagan K Sood.Hepatitis C Associated B-cell Non-Hodgkin Lymphoma:Clinical Features and the Role of Antiviral Therapy[J].Journal of Clinical and Translational Hepatology,2015,3(2):134-139. 被引量:3
  • 2栾博,卢欣荣,邓立权,金龙洙.延边朝鲜族自治州丙型肝炎患者对丙型肝炎的认知现状[J].慢性病学杂志,2013,13(3):168-171. 被引量:3
  • 3刘雪松.丙型肝炎防治指南[J].中华医学杂志,2004,84(9):775-780. 被引量:64
  • 4严艳,李卓,郭向华,林尊会.北京地区慢性丙型肝炎患者血清HCV-RNA定量检测与基因分型的研究[J].医学理论与实践,2007,20(7):756-757. 被引量:27
  • 5Xia X,Luo J,Bai JL’et al. Epidemiology of hepatitis C vi-rus infection among injection drug users in China:system-atic review and meta-analysis [J]. Public Health, 2008,122(10) :990-1003.
  • 6Fu Y. Wang Y,Xia W,et al. New trends of HCV infectionin China revealed by genetic analysis of viral sequencesdetermined from first time volunteer blood donors [Jj. JViral Hepat,2011,18(1) :42-52.
  • 7饶慧瑛,李洪,魏来,等.中国汉族人群慢性丙型肝炎患者病毒基因型和传播高危因素的演变[C].中华医学会第十六次全国病毒性肝炎及肝病学术会议论文汇编,2013,267.
  • 8Zhang CY,Wu NN,Liu J, et al. HCV subtype character-ization among injection drug users : implication for a cruci-al role of Zhenjiang in HCV transmission in China [J].PLoS One,2011,6(2):el6817.
  • 9Xia XS,Lu L, Tee KK,et al. The unique HCV genotypedistribution and the discovery of a novel subtype 6u a-mong IDUs co-infected with HIV-1 in Yunnan,China[J]. J Med Virol,2008,80(7) :1142-1152.
  • 10Dieterich DT, Rizzetto M, Manns MP. Management ofchronic hepatitis C patients who have relapsed or not re-sponded to pegylated interferon alpha plus ribavirin [J]. JViral Hepat,2009,16(12) :833-843.

共引文献52

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部